Selena Gomez Donates Funds to Lupus Research: 'I Am Hopeful for Those of Us Who May Benefit From This'

@myriameexoxo/Twitter

Selena Gomez has donated to a cause close to her heart.

The Mexican-American beauty made a financial contribution to the University of Southern California's Keck School of Medicine, and the donation will kick start a new project called the Selena Gomez Fund for Lupus Research. "I continue to be optimistic about the progress being made in lupus research and am proud to support the promising work at Keck School of Medicine," Gomez said.

"I am hopeful for the millions of us around the world that may benefit from this."

MORE: Lupus 101: What You Need to Know About Latinas & the Disease

The "Good For You" singer first opened up about her lupus diagnosis back in October of 2015, revealing she also had to undergo chemotherapy. "I locked myself away until I was confident and comfortable again," she said, on her decision to keep out of the spotlight. Then, a few months later, Gomez said she was in a "better place," with the help of proper care and rest.

In August 2016, Gomez once again addressed the issue, but in a more frustrated way. “I understand what you’re asking, but I’m just saying, I don’t think it really matters," she said in an interview with GQ. "My past seems to be way more fascinating for people than my future, which bums me out… Why do you care?”

PLUS: Selena Gomez Does Not Want to be Defined By Her Romantic Relationships

The singer is just one of the many Latinas who are diagnosed with the autoimmune disease. It occurs in one out of every 1,000 people, most often in women in their 20s and 30s. The chronic, long-term condition can affect the skin, joints, kidneys, lungs, and many other organs in the body. It often shows itself in rashes, tiredness, fever and arthritis. Though the disease does not yet have a definitive cure, Gomez's donation and project is a small step in the right direction.

Share this 
What We're Reading
Like this post? Contribute to the discussion!

Subscribe to our newsletter